The BIC International Conference is traditionally addressed to a relatively narrow selection of medical specialties since it is meant to feature only the most novel advances of basic science and clinical research in haemophilia, rare inherited coagulation disorders, von Willebrand factor and disease, gene therapy and thrombotic microangiopathies.

The BIC Conference has been organized in Italy since the 1980s by the Milan Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, held at two-three years' interval. It has gained a strong reputation among scientists and clinicians interested in haemostasis and inherited bleeding disorders, owing to the special emphasis placed by the scientific programme on the most recent progress in the field. The 2025 edition will take place in Padua and will focus primarily on the latest updates and advances in gene therapy for both haemophilias and the most common rare coagulation disorder (factor VII deficiency). In the last decade, and particularly in recent years, there have been spectacular advances in the field, stemming from basic science that has had a direct impact on patient treatment. Against this backdrop, a range of new discoveries in both basic and clinical science will be presented by invited speakers chosen by the International Committee, which includes scientists from the USA, Canada, the UK, Ireland, France, Germany, Switzerland, and Italy. These experts will present new, as yet unpublished data and discuss them with their peers. In addition to these scientific sessions, it is a tradition of the Conference to feature also lively sessions based on original abstracts submitted competitively by researchers, and selected by the Scientific Committee. Furthermore, pharmaceutical companies will have the opportunity to organize educational satellite symposia on relevant topics. Overall, the tradition and the well-established format of this Conference should ensure its continued attraction and international participation by scientists and clinicians interested in hemostasis, in particular bleeding disorders and thrombotic microangiopathies.

ORGANIZED BY

WITH THE PATRONAGE OF

DON'T FORGET TO SUBSCRIBE TO OUR FREE NEWSLETTER TO MAKE SURE YOU RECEIVE THE REGULAR PROGRAMME AND OTHER UPDATES AS SOON AS AVAILABLE

*MANDATORY FIELDS